Affiliation:
1. From the Department of Pharmacology (K.E.B.), Division of Pulmonary and Critical Care Medicine, Departments of Medicine and Microbiology, Carter Center for Immunology (B.M.), University of Virginia, Charlottesville, VA; and the La Jolla Institute of Allergy and Immunology (K.L.), La Jolla, CA.
Abstract
Adenosine is an endogenously released purine nucleoside that signals via 4 widely expressed G protein-coupled receptors: A
1
, A
2A
, A
2B
, and A
3
. In the setting of inflammation, the generation and release of adenosine is greatly enhanced. Neutrophils play an important role in host defense against invading pathogens and are the cellular hallmark of acute inflammation. Neutrophils both release adenosine and can respond to it via expression of all 4 adenosine receptor subtypes. At low concentrations, adenosine can act via the A
1
and A
3
adenosine receptor subtypes to promote neutrophil chemotaxis and phagocytosis. At higher concentrations, adenosine acts at the lower-affinity A
2A
and A
2B
receptors to inhibit neutrophil trafficking and effector functions such as oxidative burst, inflammatory mediator production, and granule release. Modulation of neutrophil function by adenosine is relevant in a broad array of disease models, including ischemia reperfusion injury, sepsis, and noninfectious acute lung injury. This review will summarize relevant research in order to provide a framework for understanding how adenosine directly regulates various elements of neutrophil function.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Cited by
212 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献